Please use this identifier to cite or link to this item:
https://doi.org/10.1038/s41584-022-00770-y
Title: | Endothelial function and endothelial progenitor cells in systemic lupus erythematosus | Authors: | Mak, Anselm Chan, Jerry Kok Yen |
Keywords: | Science & Technology Life Sciences & Biomedicine Rheumatology NEUTROPHIL EXTRACELLULAR TRAPS CORONARY-HEART-DISEASE CARDIOVASCULAR RISK-FACTORS FLOW-MEDIATED VASODILATION LOW-DENSITY-LIPOPROTEIN ANGIOGENIC T-CELLS NITRIC-OXIDE ACCELERATED ATHEROSCLEROSIS PREMATURE ATHEROSCLEROSIS PROMOTER POLYMORPHISM |
Issue Date: | 7-Apr-2022 | Publisher: | NATURE PORTFOLIO | Citation: | Mak, Anselm, Chan, Jerry Kok Yen (2022-04-07). Endothelial function and endothelial progenitor cells in systemic lupus erythematosus. NATURE REVIEWS RHEUMATOLOGY 18 (5) : 286-300. ScholarBank@NUS Repository. https://doi.org/10.1038/s41584-022-00770-y | Abstract: | The observations that traditional cardiovascular disease (CVD) risk factors fail to fully account for the excessive cardiovascular mortality in patients with systemic lupus erythematosus (SLE) compared with the general population have prompted in-depth investigations of non-traditional, SLE-related risk factors that contribute to cardiovascular complications in patients with SLE. Of the various perturbations of vascular physiology, endothelial dysfunction, which is believed to occur in the earliest step of atherosclerosis, has been extensively investigated for its contribution to CVD risk in SLE. Endothelial progenitor cells (EPCs), which play a crucial part in vascular repair, neovascularization and maintenance of endothelial function, are quantitatively and functionally reduced in patients with SLE. Yet, the lack of a unified definition of EPCs, standardization of the quantity and functional assessment of EPCs as well as endothelial function measurement pose challenges to the translation of endothelial function measurements and EPC levels into prognostic markers for CVD in patients with SLE. This Review discusses factors that contribute to CVD in SLE, with particular focus on how endothelial function and EPCs are evaluated currently, and how EPCs are quantitatively and functionally altered in patients with SLE. Potential strategies for the use of endothelial function measurements and EPC quantification as prognostic markers of CVD in patients with SLE, and the limitations of their prognostication potential, are also discussed. | Source Title: | NATURE REVIEWS RHEUMATOLOGY | URI: | https://scholarbank.nus.edu.sg/handle/10635/238417 | ISSN: | 1759-4790 1759-4804 |
DOI: | 10.1038/s41584-022-00770-y |
Appears in Collections: | Staff Publications Elements |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
NRR EPC EF SLE 2022.pdf | 2.66 MB | Adobe PDF | CLOSED | Published |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.